首页|中药封包结合西药治疗对气滞血瘀证腰椎间盘突出症的疗效

中药封包结合西药治疗对气滞血瘀证腰椎间盘突出症的疗效

扫码查看
目的 探讨中药封包结合西药治疗对腰椎间盘突出症(气滞血瘀证)的临床效果。方法 本研究共纳入125例腰椎间盘突出症患者,所有病例均来源于安阳市中医院,选取时间为2021年9月至2023年9月,根据治疗方法将患者分为对照组(62例,常规西药治疗)和研究组(63例,中药封包结合西药治疗)。对比2组患者治疗后前后中医证候积分、视觉模拟疼痛量表(VAS)评分、Oswestry功能障碍指数(ODI)量表、日本骨科协会下腰痛评估问卷(JOA)评分,治疗前后各项血清学指标以及2组患者不良反应发生情况。结果 治疗后2组患者各项中医证候积分较治疗前降低,研究组患者上述评分较对照组低(t=7。734、10。168、7。884、8。912,P均<0。01);治疗后2组患者VAS评分、ODI评分均较治疗前下降,研究组患者上述评分较对照组低,治疗后2组患者JOA评分较治疗前上升,研究组较对照组高(t=10。368、10。398、4。219,均P<0。01);治疗后2组患者血清前列腺素E2(PGE2)、肿瘤坏死因子-α(TNF-α)、转化生长因子β1(TGF-β1)、重组人基质金属蛋白酶3(MMP-3)水平均较治疗前下降,研究组患者上述指标均较对照组低,而治疗后2组患者β-内啡肽(β-EP)水平较治疗前上升,研究组较对照组高(t=30。026、10。895、9。446、6。665,13。012,P均<0。01);2组患者不良反应总发生率比较,差异无统计学意义(x2=0。088,P>0。05)。结论 腰椎间盘突出症(气滞血瘀证)的治疗中采用中药封包联合常规西药治疗,可有效缓解临床症状,减轻疼痛程度与炎症反应,促进腰椎功能的恢复,并有助于腰椎纤维化程度好转,且安全性良好。
Observation on the curative effect of traditional Chinese medicine encapsulation combined with western medicine on lumbar disc herniation(Qi stagnation and blood stasis syndrome)
Objective To investigate the clinical effect of traditional Chinese medicine encapsulation combined with Western medicine on lumbar disc herniation(Qi stagnation and blood stasis syndrome).Methods A total of 125 patients with lumbar disc herniation were included in this study,all of whom were selected from Anyang City Hospital of Traditional Chinese Medicine from September 2021 to September 2023.According to treatment methods,all patients were divided into control group(62 cases treated with conventional western medicine)and study group(63 cases treated with traditional Chinese medicine packaging combined with Western medicine).Compare the following tests between the two groups before and after the treatment:TCM syndrome scores,visual analogue pain scale(VAS)scores,Oswestry disability index(ODI)scale,Japanese orthopaedic association low back pain assessment questionnaire(JOA)scores,serological indicators,and adverse reactions.Results After treatment,the scores of TCM syndrome in both groups were lower than before the treatment,and the scores in the study group were lower than those in the control group(t=7.734,10.168,7.884,8.912,all P<0.01).After treatment,VAS score and ODI score of patients in both groups were decreased compared with before the treatment,and the above scores in the study group were decreased compared with those in the control group(t=10.368,10.398,P<0.01).JOA scores in the two groups were increased compared with the control group after the treatment,and the scores in the study group were higher compared with those in the control group(t=4.219,P<0.01).After treatment,the levels of serum prostaglandin E2(PGE2),tumor necrosis factor-α(TNF-α),transforming growth factor β1(TGF-β1)and recombinant human matrix metalloproteinase 3(MMP-3)indexes in both groups were decreased compared with those before the treatment,and the above indexes in the study group were lower than those in the control group(t=30.026,10.895,9.446,6.665,all P<0.01).After treatment,β-endorphin(β-EP)index levels in both groups were increased compared with those before the treatment,and the indices in the study group were larger than those in the control group(t=13.012,P<0.01).There was no significant difference in the total incidence of adverse reactions between the two groups(x2=0.088,P>0.05).Conclusion In the treatment of lumbar disc herniation(Qi stagnation and blood stasis syndrome),traditional Chinese medicine encapsulation combined with conventional Western medicine can effectively relieve clinical symptoms and reduce pain and inflammation.This treatment method with good safety also improves lumbar function and ameliorates lumbar fibrosis.

Traditional Chinese medicine encapsulationCombined application of Chinese medicine and western medicineLumbar vertebraeSyndrome of blood stasis and Qi stagnationTreatment outcome

宋莎丽、荣红亮

展开 >

安阳市中医院骨伤一科,河南安阳 455000

中药封包 中西药合用 腰椎 血瘀气滞 治疗结果

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(14)